Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Evidence-based medicine Stories

2014-04-16 12:30:54

LONDON, April 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Predictive Diagnostics Industryhttp://www.reportbuyer.com/pharma_healthcare/diagnostics/global_predictive_diagnostics_industry.html This report analyzes the worldwide markets for Predictive Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period...

2014-04-11 16:21:38

DALLAS, April 11, 2014 /PRNewswire/ -- The "Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas,...

2014-04-10 16:24:01

Interactive workshop will provide a better understanding of methodologies used by payers and providers for evaluating medical devices, drugs, processes, and procedures PLYMOUTH MEETING, Pa., April 10, 2014 /PRNewswire-USNewswire/ -- Which approaches are best for assessing new and emerging technologies that do not have established track records? What about technologies that are already widespread? ECRI Institute, a nonprofit dedicated to researching the best approaches to improving patient...

2014-04-08 08:30:34

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/5x8d4c/molecular) has announced the addition of a new report "Molecular Diagnostics - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/5x8d4c/molecular ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes and evaluates the molecular diagnostics technologies that will play an...

2014-04-03 08:29:07

EINDHOVEN and LEIDEN, The Netherlands, April 3, 2014 /PRNewswire/ -- The combined resources of two leading technology institutes are set to create a new wave of public-private healthcare innovation Leading Dutch technology institutes CTMM (Center for Translational Molecular Medicine) and TI Pharma have joined forces, in a merger that addresses the growing interdependence of medicines and medical technology. Impressive joint track records in medical innovation...

2014-04-02 23:02:08

Using Evidence-Based Value Analysis to Drive Quality Improvement Will Be the Focus Lansdale, PA (PRWEB) April 02, 2014 Hayes, Inc., a leader in promoting better health outcomes through the use of evidence, is pleased to announce that its President and CEO, Dr. Wini Hayes, will be a guest speaker at the Spring 2014 IDN Summit & Reverse Expo being held in Orlando, FL on April 7 to April 9, 2014. Dr. Hayes will be presenting jointly with Karla Barber, RN, BSN, System Director of Clinical...

2014-03-30 23:04:34

Doctor Evidence, a leading specialty software platform and services company serving the healthcare ecosystem appoints Jeff Frimpter, MPH as Vice President of Clients Solutions to lead the company’s client engagements. Santa Monica, CA (PRWEB) March 30, 2014 Doctor Evidence (DRE) announced today the appointment of Jeff Frimpter, MPH, as Vice President of Client Solutions. Mr. Frimpter will join the company on March 31 and will be responsible for leading DRE’s client engagements to...

2014-03-25 16:25:46

Panel Will Provide Expertise on Trial Selection, Design and Implementation WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today appointed 10 people as members of PCORI's new Advisory Panel on Clinical Trials. It is one of two new advisory panels whose members the Board approved at its meeting today; the other focuses on rare disease. Members of the Advisory Panel on Clinical Trials will support...

2014-03-24 23:03:35

GIA announces the release of a comprehensive global report on Personalized Medicines markets. Global market for Personalized Medicines is projected to reach US$200 billion by 2020, driven by aging population, escalating healthcare costs, growing focus on improving patient outcomes and the ensuing need for more effective therapies and treatment options. San Jose, CA (PRWEB) March 24, 2014 Follow us on LinkedIn -Conventional trial and error treatment method based mass prescription...

2014-03-19 08:28:52

Partnership Seeks To Establish Clinical and Health Economic Benefits of Trovagene's Urine-Based Cell-Free Molecular Diagnostics for Potential Adoption in Cancer Management Strategies SAN DIEGO and BALTIMORE, March 19, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) and Catholic Health Initiatives Center for Translational Research (CTR) today announced they have entered into a strategic partnership to conduct clinical validation studies, clinical utility studies, health economic...